targomedGmbH
12
0
1
10
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 12 trials
100.0%
+13.5% vs industry average
8%
1 trials in Phase 3/4
0%
0 of 10 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (12)
Toric Performance And Constant Evaluation
Role: collaborator
PMCF Study on EDOF (Isopure) vs Monofocal (Micropure) IOL
Role: collaborator
Comparison of ISOPURE and EYHANCE (Switzerland)
Role: collaborator
Multicentric Clinical Study on Isatis TF Trifocal Intraocular Lens
Role: collaborator
Clinical Study to Evaluate Clinical Outcomes of LuxSmart IOL as Compared With LuxGood IOL
Role: collaborator
PMCF Study on Monofocal Toric IOL (PODEYE TORIC) in Asia
Role: collaborator
PMCF Study on Monofocal Toric IOL (PODEYE TORIC)
Role: collaborator
PMCF Study on Monofocal Toric IOL (PODEYE TORIC) in Spain
Role: collaborator
PMCF Study on Monofocal Toric IOL (PODEYE TORIC) in Europe (PHY2104)
Role: collaborator
PMCF Study on Comparison of EDOF Lenses (Switzerland)
Role: collaborator
PMCF Retrospective Study Outcomes of a Premium Monofocal IOL
Role: collaborator
Rotational Stability Analysis of a Toric Monofocal IOL
Role: collaborator
All 12 trials loaded